Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
Manuel F. Ugarte‐Gil, John G. Hanly, Murray B. Urowitz, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Díaz, Jorge Sánchez‐Guerrero, Sasha Bernatsky, Ann E. Clarke, Daniel J. Wallace, David Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Ronald van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz‐Irastorza, Sam Lim, Murat İnanç, Kenneth Kalunian, Søren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Bernardo A. Pons‐Estel, Graciela S. Alarcón
Topics & Concepts
MedicineSystemic lupusSystemic lupus erythematosusCohortDiseaseSystemic diseaseAccrualInternal medicineImmunologyAccountingBusinessEarningsSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesMultiple Sclerosis Research Studies